Cyclosporine A in Reperfused Myocardial Infarction the Multicenter, Controlled, Open-Label CYCLE Trial

Journal of the American College of Cardiology

Volumn 67, Issue 4, 2016, Pages 365-374

  Ottani, Filippo ^a   Latini, Roberto ^b   Staszewsky, Lidia ^b   La Vecchia, Luigi ^c   Locuratolo, Nicola ^d   Sicuro, Marco ^e   Masson, Serge ^b   Barlera, Simona ^b   Milani, Valentina ^b   Lombardi, Mario ^f   Costalunga, Alessandra ^g   Mollichelli, Nadia ^h   Santarelli, Andrea ⁱ   De Cesare, Nicoletta ^j   Sganzerla, Paolo ^k   Boi, Alberto ^l   Maggioni, Aldo Pietro ^m   Limbruno, Ugo ⁿ  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d San Paolo Hospital   (Italy)

^e Ospedale Umberto Parini   (Italy)

^f Pediatria II   (Italy)

^g BOLOGNINI HOSPITAL   (Italy)

^h Azienda Ospedaliera di Vimercate   (Italy)

ⁱ Osp Infermi   (Italy)

^j Istituto di Cardiologia   (Italy)

^k TREVIGLIO HOSPITAL   (Italy)

^l BROTZU HOSPITAL   (Italy)

^m ANMCO RESEARCH CENTER   (Italy)

ⁿ Ospedale Delle Misericordie   (Italy)

more..

Author keywords

acute myocardial infarction; echocardiography; left ventricular function; troponins

Indexed keywords

CYCLOSPORIN A; TROPONIN T; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE ASSESSMENT; CONTROLLED STUDY; CORONARY CARE UNIT; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSED MYOCARDIAL INFARCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; DOSE RESPONSE; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84959369033     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.081     Document Type: Article

References (40)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
2. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
3. S.D. Kristensen, K.G. Laut, J. Fajadet, et al. European Association for Percutaneous Cardiovascular Interventions Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries Eur Heart J 35 2014 1957 1970
4. G. Heusch Cardioprotection: chances and challenges of its translation to the clinic Lancet 381 2013 166 175
5. R.S. Vander Heide, and C. Steenbergen Cardioprotection and myocardial reperfusion: pitfalls to clinical application Circ Res 113 2013 464 477
6. D.J. Hausenloy, and D.M. Yellon Myocardial ischemia-reperfusion injury: a neglected therapeutic target J Clin Invest 123 2013 92 100
7. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
8. P. Bernardi, and F. Di Lisa The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection J Mol Cell Cardiol 78 2015 100 106
9. H.E. Bøtker Mitochondrial care in acute myocardial infarction Eur Heart J 36 2015 77 79
10. C. Piot, P. Croisille, P. Staat, and et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
11. N. Mewton, P. Croisille, G. Gahide, and et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction J Am Coll Cardiol 55 2010 1200 1205
12. D.J. Hausenloy, and D.M. Yellon Time to take myocardial reperfusion injury seriously N Engl J Med 359 2008 518 520
13. B. Ibáñez, G. Heusch, M. Ovize, and et al. Evolving therapies for myocardial ischemia/reperfusion injury J Am Coll Cardiol 65 2015 1454 1471
14. S. Ghaffari, B. Kazemi, M. Toluey, and et al. The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction Cardiovasc Ther 31 2013 e34 e39
15. W.Y. Lim, C.M. Messow, and C. Berry Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis Br J Pharmacol 165 2012 2034 2043
16. T.T. Cung, O. Morel, G. Cayla, and et al. Cyclosporine before PCI in patients with acute myocardial infarction N Engl J Med 373 2015 1021 1031
17. R.M. Lang, M. Bierig, R.B. Devereux, and et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
18. C.E. Buller, Y. Fu, K.W. Mahaffey, and et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation 118 2008 1335 1346
19. M.C. Tjandrawidjaja, Y. Fu, C.M. Westerhout, and et al. Resolution of ST-segment depression: a new prognostic marker in ST-segment elevation myocardial infarction Eur Heart J 31 2010 573 581
20. E. Giannitsis, H. Steen, K. Kurz, and et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T J Am Coll Cardiol 51 2008 307 314
21. H. Steen, E. Giannitsis, S. Futterer, and et al. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function J Am Coll Cardiol 48 2006 2192 2194
22. K. Kurz, C. Schild, P. Isfort, and et al. Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction Clin Res Cardiol 98 2009 94 100
23. T.S. Hall, J. Hallén, M.W. Krucoff, and et al. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction Am Heart J 169 2015 257 265.e1
24. R.A. Kuiper, M.M. Malingré, J.H. Beijnen, and et al. Cyclosporine-induced anaphylaxis Ann Pharmacother 34 2000 858 861
25. G.W. Volcheck, and R.G. Van Dellen Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review Ann Allergy Asthma Immunol 80 1998 159 163
26. M. Liau-Chu, J.G. Theis, and G. Koren Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine Ann Pharmacother 31 1997 1287 1291
27. L.O. Karlsson, A.X. Zhou, E. Larsson, and et al. Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model J Cardiovasc Pharmacol Ther 15 2010 182 189
28. D. Atar, H. Arheden, A. Berdeaux, and et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results Eur Heart J 36 2015 112 119
29. J. Lønborg, N. Vejlstrup, H. Kelbæk, and et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
30. M. Kitakaze, M. Asakura, J. Kim, et al. J-WIND investigators Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials Lancet 370 2007 1483 1493
31. H.E. Bøtker, R. Kharbanda, M.R. Schmidt, and et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
32. S.K. White, G.M. Frohlich, D.M. Sado, and et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol Intv 8 2015 178 188
33. H. Bulluck, and D.J. Hausenloy Ischaemic conditioning: are we there yet? Heart 101 2015 1067 1077
34. B. Ibáñez, C. Macaya, V. Sánchez-Brunete, and et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
35. G. Pizarro, L. Fernández-Friera, V. Fuster, and et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) J Am Coll Cardiol 63 2014 2356 2362
36. D.J. Lefer, and R. Bolli Development of an NIH Consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation J Cardiovasc Pharmacol Ther 16 2011 332 339
37. S.P. Jones, X.L. Tang, Y. Guo, and et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs Circ Res 116 2015 572 586
38. F. Robicsek, and J. Schaper Reperfusion injury: fact or myth? J Card Surg 12 1997 133 137
39. R.A. Kloner Does reperfusion injury exist in humans? J Am Coll Cardiol 21 1993 537 545
40. K. Matsumura, R.W. Jeremy, J. Schaper, and et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium Circulation 97 1998 795 804